loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Darinaparsin

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Darinaparsin

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Solasia Pharma: DARVIAS Injection 135mg Approved in Japan
    Solasia Pharma: DARVIAS Injection 135mg Approved in Japan

    19 Jun 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220620005030/en

    BUSINESSWIRE
    19 Jun 2022
    Share Share
    Solasia, Nippon Kayaku Partner in Japan for DARINAPARSIN (SP-02)
    Solasia, Nippon Kayaku Partner in Japan for DARINAPARSIN (SP-02)

    26 Oct 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211026005660/en

    BUSINESSWIRE
    26 Oct 2021
    Share Share
    Solasia announces the filing of a new regulatory filing for DARINAPARSIN
    Solasia announces the filing of a new regulatory filing for DARINAPARSIN

    30 Jun 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210630006008/de

    BUSINESSWIRE
    30 Jun 2021
    Share Share
    Solasia Announces Positive Results of DARINAPARSIN in Pivotal Phase 2 Study
    Solasia Announces Positive Results of DARINAPARSIN in Pivotal Phase 2 Study

    14 Jun 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200615005228/en

    BUSINESSWIRE
    14 Jun 2020
    Share Share